新冠感染后喉功能障碍:TriNetX回顾性队列研究
本研究基于TriNetX全球电子病历网络,纳入无既往喉功能障碍或重大合并症的成人,按新冠暴露分层并与未感染者比较,评估感染后5年内喉功能障碍发生率。结果显示新冠感染与慢性咳嗽、吞咽困难、嗓音障碍、声带麻痹及喉痉挛的 odds 显著升高相关,多数结局在感染后1-2年达峰,喉痉挛在2-3年达峰。住院和机械通气与吞咽困难、嗓音障碍及声带麻痹风险升高相关,但慢性咳嗽风险降低;接种疫苗者慢性咳嗽和嗓音障碍风险较高。
要点
- 新冠感染后慢性咳嗽、吞咽困难、嗓音障碍、声带麻痹及喉痉挛风险均显著升高。
- 多数喉功能障碍结局在感染后1-2年达峰,喉痉挛在2-3年达峰。
- 住院和机械通气与吞咽困难、嗓音障碍及声带麻痹风险升高相关。
核心结论
- 新冠感染与新增喉功能障碍发生率升高相关,多数结局在感染后1-2年达峰。
- 住院、机械通气及疫苗接种状态影响喉功能障碍的发生风险。
研究设计与样本
- 成人无既往喉功能障碍或重大合并症,按新冠暴露分层并与未感染对照比较。
- 采用倾向评分匹配后计算比值比(OR)和风险差(RD)及95%置信区间(CI)。
主要发现
- 新冠感染与慢性咳嗽风险升高相关(峰值OR 7.12;RD 0.33%,p < 0.0001)。
- 新冠感染与吞咽困难风险升高相关(峰值OR 2.71;RD 0.36%,p < 0.0001)。
- 新冠感染与嗓音障碍风险升高相关(峰值OR 3.25;RD 0.12%,p < 0.0001)。
- 新冠感染与声带麻痹风险升高相关(峰值OR 2.17;RD 0.01%,p < 0.0001)。
- 新冠感染与喉痉挛风险升高相关(峰值OR 2.79;RD 0.003%,p < 0.0001)。
关键数值与推荐
- 住院与吞咽困难风险升高相关(HR 2.63),机械通气与吞咽困难风险升高相关(HR 5.26)。
- 住院与嗓音障碍风险升高相关(HR 1.15),机械通气与嗓音障碍风险升高相关(HR 4.45)。
- 住院与声带麻痹风险升高相关(HR 2.09),机械通气与声带麻痹风险升高相关(HR 9.35)。
- 住院与慢性咳嗽风险降低相关(HR 0.68),机械通气与慢性咳嗽风险降低相关(HR 0.45)。
- 接种疫苗者慢性咳嗽风险较高(HR 1.36),嗓音障碍风险较高(HR 1.22)。
临床怎么用
- 对新冠感染后出现慢性咳嗽、吞咽困难、嗓音障碍等症状的患者应警惕喉功能障碍。
- 感染后1-2年为多数喉功能障碍高发期,喉痉挛高发期可延至2-3年,随访时需关注。
- 有住院或机械通气史的新冠患者应重点评估吞咽功能、嗓音及声带运动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE(S): Long COVID affects multiple organ systems, yet the incidence and risk factors for post-COVID-19 laryngeal dysfunction remain underexplored. This study evaluated the incidence of laryngeal dysfunction following COVID-19. METHODS: A retrospective cohort study was performed using the TriNetX Global Collaborative EHR Network (> 180 million records). Adults without prior laryngeal dysfunction or major comorbidities were stratified by COVID-19 exposure and compared with uninfected controls. Outcomes included chronic cough, dysphagia, voice disorders, vocal fold paralysis, and laryngeal spasm, assessed up to 5 years post-infection. After propensity score matching, odds ratios (OR) and risk differences (RD) with 95% confidence intervals (CI) were calculated. RESULTS: COVID-19 was associated with significantly increased odds of chronic cough (peak OR 7.12; RD 0.33%, p < 0.0001), dysphagia (peak OR 2.71; RD 0.36%, p < 0.0001), voice disorders (peak OR 3.25; RD 0.12%, p < 0.0001), vocal fold paralysis (peak OR 2.17; RD 0.01%, p < 0.0001), and laryngeal spasm (peak OR 2.79; RD 0.003%, p < 0.0001). Incidence peaked at 1-2 years for most outcomes and at 2-3 years for laryngeal spasm. Hospitalization and mechanical ventilation were associated with increased rates of dysphagia (HR 2.63; HR 5.26), voice disorders (HR 1.15; HR 4.45), and vocal cord paralysis (HR 2.09; HR 9.35), but reduced rates of chronic cough (HR 0.68; HR 0.45). Vaccinated patients showed higher rates of chronic cough (HR 1.36) and voice disorders (HR 1.22). CONCLUSION: COVID-19 is associated with increased incidence of new-onset laryngeal dysfunction, most commonly peaking 1-2 years after infection and influenced by hospitalization, mechanical ventilation, and vaccination status.
引用
- Loblundo C, Chun WB, Nguyen SA, et al. Laryngeal Dysfunction Following COVID-19: A TriNetX Retrospective Cohort Study. Laryngoscope. 2026. PMID: 42059350. doi:10.1002/lary.70590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。